Insulin resistance, renal injury, renal 1-α hydroxylase, and bone Homeostasis in aged obese rats

被引:11
作者
Chang-Quan, Huang [1 ]
Bi-Rong, Dong [1 ]
Ping, He [1 ]
Zhen-Chan, Lu [1 ]
Xiao-Dong, Peng [1 ]
机构
[1] Sichuan Univ, W China Hosp, Dept Gerontol, Sichuan, Peoples R China
关键词
obesity; insulin resistance; renal 1-alpha hydroxylase; bone mineral density; aged;
D O I
10.1016/j.arcmed.2007.12.008
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
Background. This study aimed to explore the relationship among insulin resistance (IR), renal injury, renal 1-alpha hydroxylase activity (RHA), and bone homeostasis in the presence of obesity. Methods. Obesity, obesity treated with vitamin D, and obesity treated with 1-alpha hydroxyvitamin D [1-alpha(OH)D] were studied in animal models using aged Wistar rats. Glucose infusion rates (GIR), levels of urinary albumin (UA), serum 25-hydroxyvitamin D [25(OH)D], serum 1,25-dihydroxyvitamin D [1,25(OH)(2)D], and bone mineral density (BMD) in lumbar vertebrae and femoral bone were measured. Results. GIR in obese rats decreased. A negative correlation existed between UA level and GIR in the aged obese rats, which did not exist in the normal control rats. Levels of serum 25(OH)D in all models were similar. Obese rats had lower levels of serum 1,25(OH)(2)D and BMD than normal control rats. Treating obese rats with vitamin D had no effect on levels of serum 25-(OH)D, serum 1,25(OH)(2)D, and BMD. Administration of 1 alpha-(OH)D to obese rats significantly increased serum 1,25(OH)(2)D to above-normal levels and BMD to normal level. In obese rats, levels of serum 1,25(OH)(2)D and BMD in lumbar vertebrae and femoral bone were positively correlated with GIR, and the level of serum 1,25(OH)(2)D was negatively correlated with the UA level. Conclusions. In the presence of obesity, IR, renal injury, decrease in RHA and bone loss exist. IR-injured kidney accounts for a decrease in RHA, which is a precipitating factor for bone loss. (C) 2008 IMSS. Published by Elsevier Inc.
引用
收藏
页码:380 / 387
页数:8
相关论文
共 43 条
[1]
Overview: Obesity: What does it have to do with kidney disease? [J].
Abrass, CK .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (11) :2768-2772
[2]
INFLUENCE OF GLUCAGON ON GFR AND ON UREA AND ELECTROLYTE EXCRETION - DIRECT AND INDIRECT EFFECTS [J].
AHLOULAY, M ;
DECHAUX, M ;
LABORDE, K ;
BANKIR, L .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1995, 269 (02) :F225-F235
[3]
Parathyroid hormone stimulation of the renal 25-hydroxyvitamin D-1α-hydroxylase -: Effect of age and free radicals [J].
Armbrecht, H. J. ;
Boltz, M. A. ;
Ritter, C. S. ;
Brown, A. J. .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5) :330-333
[4]
BLAEDEL WJ, 1975, CLIN CHEM, V21, P119
[5]
Boucher BJ, 2006, DIABETIC MED, V23, P336, DOI 10.1111/j.1464-5491.2006.01825a.x
[6]
Health hazards of obesity [J].
Bray, GA .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1996, 25 (04) :907-+
[7]
Broholm B, 2005, SPINAL CORD, V43, P674, DOI 10.1038/sj.sc.3101788
[8]
Chan JCN, 1996, DIABETIC MED, V13, P150, DOI 10.1002/(SICI)1096-9136(199602)13:2<150::AID-DIA33>3.3.CO
[9]
2-A
[10]
Diabetic vascular complications [J].
Cooper, ME ;
Gilbert, RE ;
Jerums, G .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (9-10) :770-775